On February 5, 2019, Kathie J. Lenzen notified Xtant Medical Holdings, Inc. of her resignation as Senior Vice President, Finance & Administration and Chief Financial Officer, effective February 26, 2019, for personal reasons. Effective February 11, 2019, the Company appointed Greg Jensen as Vice President, Finance and Interim Chief Financial Officer. Mr. Jensen served as a Financial Executive Advisor from May 2005 to February 2019 at GPJ Consulting LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7511 USD | -2.15% | +4.30% | -33.53% |
05-15 | Earnings Flash (XTNT) XTANT MEDICAL HOLDINGS Reports Q1 Revenue $27.9M, vs. Street Est of $25.8M | MT |
05-15 | Transcript : Xtant Medical Holdings, Inc., Q1 2024 Earnings Call, May 15, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.53% | 97.81M | |
+12.05% | 128B | |
-9.24% | 10.88B | |
+0.29% | 8.76B | |
+36.99% | 5.48B | |
-21.98% | 4.72B | |
+8.02% | 3.43B | |
-10.32% | 2.76B | |
-12.33% | 2.06B | |
-13.53% | 1.92B |
- Stock Market
- Equities
- XTNT Stock
- News Xtant Medical Holdings, Inc.
- Xtant Medical Holdings, Inc. Announces Executive Changes